Tyler Alban (@tyleralban1) 's Twitter Profile
Tyler Alban

@tyleralban1

PhD in Molecular Medicine. Currently working on immunotherapies in cancer at the Lerner Research Institute

ID: 913546216935510016

calendar_today28-09-2017 23:29:25

580 Tweet

504 Followers

547 Following

Tyler Alban (@tyleralban1) 's Twitter Profile Photo

So grateful for the experience to work with ⁦Pallavi Tiwari⁩ and ⁦Ruchika Verma⁩ combining deep learning with genomics to identify sexually diamorphic characteristics of #GBM !! science.org/doi/10.1126/sc…

Justin Lathia, PhD 🧠🕺🏽 (@justinlathia) 's Twitter Profile Photo

Great to see our review out on macrophage migration inhibitory factor (MIF, most important factor, 😉) as a #TME modulator in Neuro-Oncology Advances pubmed.ncbi.nlm.nih.gov/39233830/ - congrats to @CleClinicLCM medical student Jakub Jarmula on leading this effort, supported by American Brain Tumor Association

Tyler Alban (@tyleralban1) 's Twitter Profile Photo

Taking some much needed rest and traveling out west for some mountain biking and hiking the back country of Montana and Wyoming.

Taking some much needed rest and traveling out west for some mountain biking and hiking the back country of Montana and Wyoming.
Human Immunology News (@humanimmunenews) 's Twitter Profile Photo

Researchers led by Tyler Alban and Nadeem Riaz (Nadeem Riaz) showed on a large scale that mutations producing #neoantigen-reactive T cells are likely to decrease in frequency during therapy, consistent with therapy-induced immunoediting. ✏️ 👉 go.nature.com/3XRl4vo

Researchers led by <a href="/TylerAlban1/">Tyler Alban</a> and Nadeem Riaz (<a href="/xrtGenomics/">Nadeem Riaz</a>) showed on a large scale that mutations producing #neoantigen-reactive T cells are likely to decrease in frequency during therapy, consistent with therapy-induced immunoediting. ✏️ 

👉 go.nature.com/3XRl4vo
Ben Creelan, MD (@bencreelan) 's Twitter Profile Photo

Excited to be part of team science published today in Nature Medicine with Tyler Alban 🗞️ Both NSCLC responders and non-responders had anti-tumor T cells. Responders target clonal antigens. 👉rdcu.be/dVyiU

Excited to be part of team science published today in <a href="/NatureMedicine/">Nature Medicine</a> with <a href="/TylerAlban1/">Tyler Alban</a> 🗞️

Both NSCLC responders and non-responders had anti-tumor T cells. Responders target clonal antigens.   
👉rdcu.be/dVyiU
Tyler Alban (@tyleralban1) 's Twitter Profile Photo

Excited to share our manuscript on quantum machine learning! I’m a believer in team science so here we teamed up with quantum computing experts from IBM Research and used quantum ensemble approaches for modeling transcriptomic data to predict IO response. arxiv.org/abs/2506.02213

Justin Lathia, PhD 🧠🕺🏽 (@justinlathia) 's Twitter Profile Photo

Great to have John Metzcar visit us yesterday and share insights into how mathematical modeling can inform #GBM growth! Looking forward to continuing these exciting collaborations!

Great to have <a href="/jmetzcar/">John Metzcar</a> visit us yesterday and share insights into how mathematical modeling can inform #GBM growth! Looking forward to continuing these exciting collaborations!